Leprostatics (Systemic single ingredient)

The phrase "Leprostatics (Systemic single ingredient)" is an administrative and formulary classification rather than a formal standalone pharmacological class

The phrase "Leprostatics (Systemic single ingredient)" is an administrative and formulary classification rather than a formal standalone pharmacological class It denotes systemic, single-agent antimycobacterial drugs—most prominently dapsone and clofazimine—formulated to suppress the replication of *Mycobacterium leprae*

The phrase "Leprostatics (Systemic single ingredient)" is an administrative and formulary classification rather than a formal standalone pharmacological class

It denotes systemic, single-agent antimycobacterial drugs—most prominently dapsone and clofazimine—formulated to suppress the replication of *Mycobacterium leprae*

It denotes systemic, single-agent antimycobacterial drugs—most prominently dapsone and clofazimine—formulated to suppress the replication of *Mycobacterium leprae* These agents primarily function by inhibiting essential bacterial processes, such as dihydropteroate synthase in folic acid synthesis or mycobacterial DNA and membrane dynamics

These agents primarily function by inhibiting essential bacterial processes, such as dihydropteroate synthase in folic acid synthesis or mycobacterial DNA and membrane dynamics

These agents primarily function by inhibiting essential bacterial processes, such as dihydropteroate synthase in folic acid synthesis or mycobacterial DNA and membrane dynamics

Clinically, they are key components of World Health Organization–recommended multidrug regimens for Hansen disease (leprosy) and are also utilized for related inflammatory dermatoses, such as dermatitis herpetiformis

Clinically, they are key components of World Health Organization–recommended multidrug regimens for Hansen disease (leprosy) and are also utilized for related inflammatory dermatoses, such as dermatitis herpetiformis